CN102746351A - 灯盏花乙素及其类似物的制备方法 - Google Patents
灯盏花乙素及其类似物的制备方法 Download PDFInfo
- Publication number
- CN102746351A CN102746351A CN2012102547288A CN201210254728A CN102746351A CN 102746351 A CN102746351 A CN 102746351A CN 2012102547288 A CN2012102547288 A CN 2012102547288A CN 201210254728 A CN201210254728 A CN 201210254728A CN 102746351 A CN102746351 A CN 102746351A
- Authority
- CN
- China
- Prior art keywords
- compound
- lamp
- reaction scheme
- dish flower
- flower acetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title abstract description 13
- DJSISFGPUUYILV-UHFFFAOYSA-N UNPD161792 Natural products O1C(C(O)=O)C(O)C(O)C(O)C1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-UHFFFAOYSA-N 0.000 title abstract description 4
- NPLTVGMLNDMOQE-UHFFFAOYSA-N carthamidin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=C(O)C(O)=C2C(=O)C1 NPLTVGMLNDMOQE-UHFFFAOYSA-N 0.000 title abstract description 4
- 229930190376 scutellarin Natural products 0.000 title abstract description 4
- DJSISFGPUUYILV-ZFORQUDYSA-N scutellarin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC(O)=CC=1)O2 DJSISFGPUUYILV-ZFORQUDYSA-N 0.000 title abstract 5
- 150000001875 compounds Chemical class 0.000 claims abstract description 48
- 238000006243 chemical reaction Methods 0.000 claims abstract description 32
- 239000002253 acid Substances 0.000 claims abstract description 16
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 claims abstract description 8
- 229940117954 naringenin Drugs 0.000 claims abstract description 8
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000007625 naringenin Nutrition 0.000 claims abstract description 8
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 claims abstract description 3
- 230000000694 effects Effects 0.000 claims description 12
- 230000014509 gene expression Effects 0.000 claims description 12
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims description 11
- 229940125758 compound 15 Drugs 0.000 claims description 11
- 229920000151 polyglycol Polymers 0.000 claims description 9
- 239000010695 polyglycol Substances 0.000 claims description 9
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 8
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- -1 polyoxyethylene Polymers 0.000 claims description 6
- 235000013824 polyphenols Nutrition 0.000 claims description 6
- 235000015320 potassium carbonate Nutrition 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 claims description 5
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 claims description 5
- 229940126208 compound 22 Drugs 0.000 claims description 5
- 229940125961 compound 24 Drugs 0.000 claims description 5
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 4
- 239000002994 raw material Substances 0.000 abstract description 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 4
- 150000008131 glucosides Chemical class 0.000 description 4
- 229940097043 glucuronic acid Drugs 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 2
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940126543 compound 14 Drugs 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- YWGHUJQYGPDNKT-UHFFFAOYSA-N hexanoyl chloride Chemical compound CCCCCC(Cl)=O YWGHUJQYGPDNKT-UHFFFAOYSA-N 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 1
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DRUIESSIVFYOMK-UHFFFAOYSA-N Trichloroacetonitrile Chemical compound ClC(Cl)(Cl)C#N DRUIESSIVFYOMK-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- NGXUUAFYUCOICP-UHFFFAOYSA-N aminometradine Chemical group CCN1C(=O)C=C(N)N(CC=C)C1=O NGXUUAFYUCOICP-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126142 compound 16 Drugs 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BXEMXLDMNMKWPV-UHFFFAOYSA-N pyridine Chemical compound C1=CC=NC=C1.C1=CC=NC=C1 BXEMXLDMNMKWPV-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210254728.8A CN102746351B (zh) | 2012-07-23 | 2012-07-23 | 灯盏花乙素及其类似物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210254728.8A CN102746351B (zh) | 2012-07-23 | 2012-07-23 | 灯盏花乙素及其类似物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102746351A true CN102746351A (zh) | 2012-10-24 |
CN102746351B CN102746351B (zh) | 2018-03-02 |
Family
ID=47026889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210254728.8A Active CN102746351B (zh) | 2012-07-23 | 2012-07-23 | 灯盏花乙素及其类似物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102746351B (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105218606A (zh) * | 2015-10-19 | 2016-01-06 | 昆明理工大学 | 一种制备灯盏乙素的方法 |
CN111484538A (zh) * | 2019-01-29 | 2020-08-04 | 复旦大学 | 一种高车前苷的制备方法 |
US11104697B2 (en) | 2019-05-20 | 2021-08-31 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11111263B2 (en) | 2019-05-20 | 2021-09-07 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11110110B2 (en) | 2017-11-24 | 2021-09-07 | H. Lundbeck A/S | Catecholamine prodrugs for use in the treatment of Parkinson's disease |
US11130775B2 (en) | 2019-05-20 | 2021-09-28 | H. Lundbeck A/S | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11168056B2 (en) | 2019-05-20 | 2021-11-09 | H. Lundbeck A/S | Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101486744A (zh) * | 2009-02-25 | 2009-07-22 | 江苏先声药物研究有限公司 | 聚乙二醇修饰的灯盏花乙素化合物及其制备方法 |
CN101538299A (zh) * | 2009-04-29 | 2009-09-23 | 四川抗菌素工业研究所有限公司 | 一种合成5,6,4’-三羟基黄酮-7-0-d-葡萄糖醛酸的方法 |
WO2010028187A2 (en) * | 2008-09-03 | 2010-03-11 | Bionovo, Inc. | Methods and compositions for the treatment of cancer |
CN101891728A (zh) * | 2010-05-20 | 2010-11-24 | 南京中医药大学 | 灯盏乙素苷元衍生物及其制备方法和其应用 |
CN101941999A (zh) * | 2009-07-07 | 2011-01-12 | 昆明制药集团股份有限公司 | 一种制备灯盏花乙素的方法 |
CN102134186A (zh) * | 2010-01-25 | 2011-07-27 | 昆明制药集团股份有限公司 | 一种制备灯盏花乙素中间体的方法 |
CN102344475A (zh) * | 2010-07-30 | 2012-02-08 | 昆明制药集团股份有限公司 | 一种灯盏花乙素衍生物及其制备方法和应用 |
-
2012
- 2012-07-23 CN CN201210254728.8A patent/CN102746351B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010028187A2 (en) * | 2008-09-03 | 2010-03-11 | Bionovo, Inc. | Methods and compositions for the treatment of cancer |
CN101486744A (zh) * | 2009-02-25 | 2009-07-22 | 江苏先声药物研究有限公司 | 聚乙二醇修饰的灯盏花乙素化合物及其制备方法 |
CN101538299A (zh) * | 2009-04-29 | 2009-09-23 | 四川抗菌素工业研究所有限公司 | 一种合成5,6,4’-三羟基黄酮-7-0-d-葡萄糖醛酸的方法 |
CN101941999A (zh) * | 2009-07-07 | 2011-01-12 | 昆明制药集团股份有限公司 | 一种制备灯盏花乙素的方法 |
CN102134186A (zh) * | 2010-01-25 | 2011-07-27 | 昆明制药集团股份有限公司 | 一种制备灯盏花乙素中间体的方法 |
CN101891728A (zh) * | 2010-05-20 | 2010-11-24 | 南京中医药大学 | 灯盏乙素苷元衍生物及其制备方法和其应用 |
CN102344475A (zh) * | 2010-07-30 | 2012-02-08 | 昆明制药集团股份有限公司 | 一种灯盏花乙素衍生物及其制备方法和应用 |
Non-Patent Citations (3)
Title |
---|
GUOZHI LIU ET AL.: "Identification of flavonoids in the stems and leaves of scutellaria baicalensis georgi", 《JOURNAL OF CHROMATOGRAPHY B》 * |
RICARDO LUCAS ET AL.: "A concise synthesis of glucuronide metabolites of urolithin-B,resveratrol, and hydroxytyrosol", 《CARBOHYDRATE RESEARCH》 * |
任旭红等: "灯盏花乙素合成路线图解", 《中国医药导报》 * |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105218606B (zh) * | 2015-10-19 | 2017-12-01 | 昆明理工大学 | 一种制备灯盏乙素的方法 |
CN105218606A (zh) * | 2015-10-19 | 2016-01-06 | 昆明理工大学 | 一种制备灯盏乙素的方法 |
US11707476B2 (en) | 2017-11-24 | 2023-07-25 | H. Lundbeck A/S | Catecholamine prodrugs for use in the treatment of parkinson's disease |
US11110110B2 (en) | 2017-11-24 | 2021-09-07 | H. Lundbeck A/S | Catecholamine prodrugs for use in the treatment of Parkinson's disease |
CN111484538B (zh) * | 2019-01-29 | 2023-02-10 | 复旦大学 | 一种高车前苷的制备方法 |
CN111484538A (zh) * | 2019-01-29 | 2020-08-04 | 复旦大学 | 一种高车前苷的制备方法 |
US11104697B2 (en) | 2019-05-20 | 2021-08-31 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11168056B2 (en) | 2019-05-20 | 2021-11-09 | H. Lundbeck A/S | Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol |
US20220185839A1 (en) | 2019-05-20 | 2022-06-16 | H. Lundbeck A/S | Process for the manufacture of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-carboxylic acid |
US11130775B2 (en) | 2019-05-20 | 2021-09-28 | H. Lundbeck A/S | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11111263B2 (en) | 2019-05-20 | 2021-09-07 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11827665B2 (en) | 2019-05-20 | 2023-11-28 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11851456B2 (en) | 2019-05-20 | 2023-12-26 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11858954B2 (en) | 2019-05-20 | 2024-01-02 | H. Lundbeck A/S | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
US11866410B2 (en) | 2019-05-20 | 2024-01-09 | H. Lundbeck A/S | Process for the manufacturing of (6AR,10AR)-7-propyl-6,6A,7,8,9,10,10A,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4AR, 10AR)-1-propyl-1,2,3,4,4A,5,10,10A-octahydro-benzo[G]quinoline-6,7-diol |
Also Published As
Publication number | Publication date |
---|---|
CN102746351B (zh) | 2018-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102746351A (zh) | 灯盏花乙素及其类似物的制备方法 | |
CN105131054B (zh) | 用于制备磺达肝癸钠的中间体及其制备方法、磺达肝癸钠的制备方法 | |
CN111440215B (zh) | 一种微通道反应装置制备瑞德西韦的方法 | |
Avilov et al. | Triterpene glycosides from the Far-Eastern sea cucumber Pentamera calcigera. 1. Monosulfated glycosides and cytotoxicity of their unsulfated derivatives | |
Chen et al. | Structure determination and synthesis of a new cerebroside isolated from the traditional Chinese medicine Typhonium giganteum Engl. | |
CN104478706A (zh) | 一种制备甜菊醇的方法 | |
CN103833714B (zh) | 木犀草素、木犀草苷、木犀草素芸香糖苷半合成的方法 | |
Zong et al. | Design, synthesis and biological evaluation of fucose-truncated monosaccharide analogues of ipomoeassin F | |
CN1974569A (zh) | 8-辛基小檗碱盐酸盐、合成方法及应用 | |
CN103288905A (zh) | 一种合成卡培他滨的新工艺 | |
CN115785070B (zh) | 一种吡咯烷基乙酰胺衍生物、制备方法及其应用 | |
CN102180914A (zh) | 一种2-脱氧-d-葡萄糖的制备方法 | |
CN112538099A (zh) | 一种全酰基保护的1-硫代葡萄糖、葡萄糖1-硫醇的制备方法及其应用 | |
CN104387426A (zh) | 一种区域选择性合成6-o-丙烯酰基糖类衍生物的方法 | |
Zong et al. | Synthesis of a mannose hexasaccharide related to the cell wall mannan of Candida dubliniensis and Trychophyton mentagrophytes | |
CN104109182A (zh) | 一种制备盐酸吉西他滨的方法 | |
CN103374049A (zh) | 一种制备5,6,4’-三羟基黄酮-7-0-d-葡萄糖醛酸的方法 | |
JPWO2006059670A1 (ja) | キトサン複合体 | |
CN105646618A (zh) | 一种还原胺化制备加米霉素的方法 | |
CN102140124B (zh) | 一种新型的卡培他滨的合成工艺 | |
CN101891772B (zh) | 一种5’-核苷酸二钠的制备方法 | |
CN104130297A (zh) | 一种使用高效脱水剂合成卡培他滨关键中间体的方法 | |
CN114736315B (zh) | 香菇多糖核心片段β-(1→6)支链β-(1→3)主链的七糖合成方法 | |
Huang et al. | One-pot synthesis of a 3, 6-branched hexaarabinogalactan using galactopyranosyl thioglycoside diol as a key glycosylating agent | |
CN115160399B (zh) | 一种皂皮酸类化合物及其制备方法和医用用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: NANJING ABIOCHEM BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SHANGHAI LANMU CHEMICAL CO., LTD. Effective date: 20150319 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201500 JINSHAN, SHANGHAI TO: 210000 NANJING, JIANGSU PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150319 Address after: 408, room 01, 210000, Nanjing science and Technology Innovation Zone, Taishan street, 18 Si Pu Road, Pukou District, Jiangsu, China Applicant after: NANJING ABIOCHEM BIOMEDICAL TECHNOLOGY CO.,LTD. Address before: 201500 Shanghai city Jinshan District ting Lin Zhen Ting Village No. 2093 Applicant before: SHANGHAI LANMU CHEMICALS Co.,Ltd. |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180122 Address after: 201203 Chinese (Shanghai) free trade zone fanchun Road No. 400 Building 1 room 436 4 Applicant after: ABIOCHEM BIOTECHNOLOGY Co.,Ltd. Address before: 408, room 01, 210000, Nanjing science and Technology Innovation Zone, Taishan street, 18 Si Pu Road, Pukou District, Jiangsu, China Applicant before: NANJING ABIOCHEM BIOMEDICAL TECHNOLOGY CO.,LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200241 Patentee after: Ecolab Biotechnology (Shanghai) Co.,Ltd. Address before: 201203 China (Shanghai) free trade pilot area, No. 1, 4 floor, 1 room, 400 Fang Chun road. Patentee before: ABIOCHEM BIOTECHNOLOGY Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200241 Patentee after: Yikelai Biotechnology (Group) Co.,Ltd. Address before: Room 3114, Building B, 555 Dongchuan Road, Minhang District, Shanghai, 200241 Patentee before: Ecolab Biotechnology (Shanghai) Co.,Ltd. |